Chloroquine Phosphate Oral Suspension (box of 1 bottle)

*Packaging color may differ according to distribution region.

Chloroquine Phosphate Oral Suspension

ChloquinCare™

Chloroquine Phosphate Oral Suspension is an antimalarial medicine for the treatment and prevention of malaria. AdvaCare Pharma produces this drug at its ISO/GMP-certified facilities in India, China, and the USA.

Dosage

Packaging

What is Chloroquine Phosphate?

Therapeutic Class:

Antimalarial

Active Ingredients: Chloroquine Phosphate

Chloroquine Phosphate Oral Suspension is a drug used for the prevention and treatment of malaria. It is an antimalarial agent used for uncomplicated infections caused by P. falciparum, P.ovale, chloroquine-susceptible P.vivax, or Plasmodium malariae. The active ingredient, Chloroquine, is a 4-aminoquinoline.

This medication is supplied and distributed by AdvaCare Pharma. Chloroquine Phosphate Oral Suspension is produced in our GMP-certified facilities located in China, India, and the USA. We routinely inspect our production facilities to ensure our products meet quality and safety standards.

Why are we a quality Chloroquine Phosphate manufacturer?

AdvaCare Pharma, a GMP-compliant pharmaceutical company, specializes in the manufacture of Chloroquine Suspension and other high-quality pharmaceutical medicines in suspension form. Our manufacturing facilities' strategic placement ensures full control over the supply chain, ensuring enhanced product quality and decreased costs for transport and import. Chloroquine Phosphate Oral Suspension is a part of our extensive catalog of products that are available for global distribution.

Uses

What is Chloroquine Phosphate used for?

It is used to prevent and treat malaria caused by P. vivax, P. malariae, and most strains of P. falciparum.

How is Chloroquine Phosphate Oral Suspension used?

This medication has been manufactured as a liquid to be taken orally. It should be taken by mouth with or without food as directed by a doctor.

What dose should be taken?

For the prevention of malaria, Chloroquine Phosphate is given once weekly and should be administered on the same day each week. The usual dose for adults is 500mg per dose. For children under 18, the usual dose is 8.3mg/kg. The maximum dose is 500mg. Treatment should begin two weeks before traveling to the region, It should continue for eight weeks following leaving the area.

For the treatment of malaria, the usual dose for adults is 1000mg for the first dose. After the first dose, 500mg should be given every 6-8 hours. For days 3 and 4, only one dose of 500mg should be given. For children and adults with low body weight, the usual dose is 10mg/kg. After the first dose, 5mg/kg should be 6, 24, and 36 hours later.

Refer to a doctor or pharmacist for guidelines on dosage. Do not exceed what they advise.

Side Effects

As with all pharmaceuticals some unwanted effects can occur from the use of Chloroquine Phosphate.

Seek medical attention if the following develop:

bleeding gums
black or tarry stools
blurred vision
blood in the urine or stools
chest pain
diarrhea
difficulty with swallowing
dizziness
fast heartbeat
fever
skin rash
hives
itching
sweating
tightness in the chest

For a comprehensive list of all possible effects, consult a doctor.

If any symptom persists or gets worse, or you notice any other symptom, then please call your doctor immediately.

Precautions

Do NOT use Chloroquine Phosphate if:

You are allergic to any ingredient of the oral suspension.
You have vision problems or retinal changes.
You are taking arsenic, astemizole, terfenadine, cimetidine, cisapride, quinacrine, or dofetilide.

Possible interactions with this medicine may occur if:

You are taking Cimetidine or quinacrine (increasing the chloroquine side effects);
You are taking ampicillin, rabies vaccine, or thyroid hormones (decreasing the effectiveness of these medicines);
You are taking cyclosporine (because its side effects may be increased).

Consult with a doctor about any medications you are taking before your treatment with Chloroquine Phosphate Oral Suspension.

The use of Chloroquine Phosphate during pregnancy or breastfeeding should be avoided. Consult your doctor or healthcare professional before having Chloroquine Phosphate.

Driving or operating machinery should be avoided, as this drug may cause dizziness.

*Regulatory compliance may vary according to production standard, import requirements and/or manufacturing origin.